Estadísticas de Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study

Visitas totales

views
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study 0

Visitas totales por mes

views
mayo 2024 0
junio 2024 0
julio 2024 0
agosto 2024 0
septiembre 2024 0
octubre 2024 0
noviembre 2024 0

Visitas de archivo

views
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Results of an Observational Longitudinal Cohort Study.pdf 16